News
Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...
Eli Lilly and Co. will break ground on its $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana's LEAP Research and Innovation District. The foundry could bring in 400 highly skilled workers to ...
Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.
Chief Executive magazine announced April 7 that Dave Ricks, chair and CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year. Ricks is the newest member of the Purdue ...
Eli Lilly CEO David Ricks is confident that weight loss med Zepbound is gaining market share at the expense of Wegovy, even as its rival strikes deals with CVS and Hims & Hers pharmacies.
David Ricks is the CEO of Eli Lilly, the most valuable drugmaker in the world by market capitalization. Lilly is on the path to become the first trillion-dollar pharma company, fueled by the ...
It was the second drug in its class that had failed for Pfizer. Advertisement Advertisement So, David Ricks, Lilly’s CEO, was understandably cautious. It was the latest in a string of milestone ...
Lilly’s CEO Dave Ricks warned that the growth of compounding could create a “backdoor generic world.” ...
Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on foreign trade deals and warned of the harmful effects retaliatory tariffs could have on American exporters like Eli Lilly.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results